Qing Shi

5PUBLICATIONS
19CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 24, 2026
Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma.

|Jul 27, 2025
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06).

Yi-Ge Shen, Qing Shi, Wei Tang

|Apr 09, 2023
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.

Rong Shen, Di Fu, Lei Dong

|Apr 17, 2020
Advances in targeted therapy for malignant lymphoma.

Li Wang, Wei Qin, Yu-Jia Huo

|Nov 08, 2017
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.

Qing Shi, Rong Shen, Chao-Fu Wang

Pageof 1

Frequent Collaborators

3 joint publications

Wei-Li Zhao

2 joint publications

Li Wang

1 joint publications

Rong Shen

1 joint publications

Xing Fan